TAP expands its non-alcoholic portfolio with a strategic partnership and investment in Fever-Tree, targeting growth in the U.S. market.

By Shashwat Awasthi (Reuters) -Shares of Fevertree Drinks surged almost 24% after Molson Coors took an 8.5% stake in a $88 million deal that gives the beer giant exclusive rights to market the British company's cocktail mixers and tonic water in the United States.

Molson Coors Beverage Company has announced a strategic partnership with Fever-Tree in the US, aiming to fuel its premiumisation and ‘Beyond Beer’ strategies. Through the deal, Molson Coors will assume exclusive commercialisation rights to Fever-Tree’s range of tonics, ginger beers, cocktail mixers and more in the US, starting from 1 February 2025.

The Coors Light manufacturer’s 8.5% stake in the nonalcoholic carbonated mixer, worth $89 million, further builds on its long-term strategy of increasing its exposure beyond beer.

Miller Lite brewer Molson Coors (TAP) says it will expand its U.S. soft drinks business through a strategic partnership with UK-based

The London-listed mixer-maker said Molson Coors would acquire an 8.5% shareholding in Fevertree.

By Shashwat Awasthi (Reuters) -Shares of Fevertree Drinks surged almost 24% after Molson Coors' took an 8.5% stake in the firm, in a deal giving the beer giant exclusive rights to market the British company's cocktail mixers and tonic water in the United States.

Molson Coors has acquired an 8.5% stake in British drinks company Fever Tree in a £71m deal that enables the mixer brand to “unlock growth” across the US.

Fevertree sells an 8.5% stake to Molson Coors to boost its US expansion. Discover how this £71m deal, combined with an exclusive licensing agreement, might reshape the premium mixer’s future.

US brewer Molson Coors is to buy an 8.5% stake in Fevertree for £71m, with the proceeds to be returned to shareholders via a share buyback.